NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)

CUSIP: 640268108

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
29,109,163
Total 13F shares
177,174,980
Share change
+1,357,228
Total reported value
$3,164,197,295
Put/Call ratio
129%
Price per share
$17.85
Number of holders
234
Value change
+$12,315,614
Number of buys
103
Number of sells
135

Security key

640268108

Report period

Q1 2020

Institutions

234

Top holders

10

Top shareholders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Invesco Ltd.
13F
Company
109%
31,629,134
$682,714,000 31 Dec 2019
13F
PRIMECAP MANAGEMENT CO/CA/
13F
Company
69%
20,080,348
$433,434,000 31 Dec 2019
13F
BlackRock Finance, Inc.
13F
Company
63%
18,417,535
$397,543,000 31 Dec 2019
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
56%
16,174,579
$349,127,000 31 Dec 2019
13F
VANGUARD GROUP INC
13F
Company
56%
16,157,611
$348,762,000 31 Dec 2019
13F
FMR LLC
13F
Company
51%
14,938,026
$322,437,000 31 Dec 2019
13F
STATE STREET CORP
13F
Company
16%
4,550,105
$98,214,000 31 Dec 2019
13F
Camber Capital Management LP
13F
Company
13%
3,750,000
$80,944,000 31 Dec 2019
13F
Bellevue Group AG
13F
Company
12%
3,416,998
$73,756,000 31 Dec 2019
13F
MAVERICK CAPITAL LTD
13F
Company
11%
3,241,234
$69,962,000 31 Dec 2019
13F
FIRST TRUST ADVISORS LP
13F
Company
10%
2,969,452
$64,096,000 31 Dec 2019
13F
NORGES BANK
13F
Company
8.4%
2,432,006
$52,495,000 31 Dec 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
7%
2,039,646
$44,025,000 31 Dec 2019
13F
GOLDMAN SACHS GROUP INC
13F
Company
6.7%
1,953,933
$42,176,000 31 Dec 2019
13F
JPMORGAN CHASE & CO
13F
Company
6.3%
1,838,262
$39,679,000 31 Dec 2019
13F
Bank of New York Mellon Corp
13F
Company
6.3%
1,831,292
$39,529,000 31 Dec 2019
13F
NORTHERN TRUST CORP
13F
Company
4.9%
1,417,164
$30,589,000 31 Dec 2019
13F
JANUS HENDERSON GROUP PLC
13F
Company
3.9%
1,137,287
$24,548,000 31 Dec 2019
13F
Rhenman & Partners Asset Management AB
13F
Company
3.8%
1,100,000
$23,744,000 31 Dec 2019
13F
FEDERATED HERMES, INC.
13F
Company
3.5%
1,024,531
$22,115,000 31 Dec 2019
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
3.4%
985,053
$21,262,000 31 Dec 2019
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
2.7%
783,357
$16,909,000 31 Dec 2019
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
2.7%
772,730
$16,679,000 31 Dec 2019
13F
CREDIT SUISSE AG/
13F
Company
2.3%
673,138
$14,530,000 31 Dec 2019
13F
FRONTIER CAPITAL MANAGEMENT CO LLC
13F
Company
2.3%
666,400
$14,384,000 31 Dec 2019
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
2.2%
652,420
$14,082,000 31 Dec 2019
13F
DEUTSCHE BANK AG\
13F
Company
2.2%
642,358
$13,864,000 31 Dec 2019
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
2.1%
596,928
$12,885,000 31 Dec 2019
13F
MORGAN STANLEY
13F
Company
2%
577,591
$12,467,000 31 Dec 2019
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
1.8%
521,781
$11,262,000 31 Dec 2019
13F
KBC Group NV
13F
Company
1.6%
464,605
$10,028,000 31 Dec 2019
13F
AustralianSuper Pty Ltd
13F
Company
1.5%
449,470
$9,702,000 31 Dec 2019
13F
RHUMBLINE ADVISERS
13F
Company
1.5%
438,109
$9,457,000 31 Dec 2019
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
1.4%
420,265
$9,071,000 31 Dec 2019
13F
PDT Partners, LLC
13F
Company
1.4%
402,264
$8,683,000 31 Dec 2019
13F
S.c.a. Candriam
13F
Individual
1.3%
386,000
$8,332,000 31 Dec 2019
13F
AMERIPRISE FINANCIAL INC
13F
Company
1.3%
381,984
$8,245,000 31 Dec 2019
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
1.2%
354,662
$7,655,000 31 Dec 2019
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
1.2%
351,400
$7,585,000 31 Dec 2019
13F
Nuveen Asset Management, LLC
13F
Company
1.2%
338,894
$7,315,000 31 Dec 2019
13F
Swiss National Bank
13F
Company
1.2%
336,829
$7,270,000 31 Dec 2019
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
1.1%
318,375
$6,872,124 31 Dec 2019
13F
GROUP ONE TRADING LLC
13F
Company
1.1%
315,728
$6,815,000 31 Dec 2019
13F
Duquesne Family Office LLC
13F
Company
1.1%
310,579
$6,704,000 31 Dec 2019
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
1.1%
307,895
$6,646,000 31 Dec 2019
13F
Legal & General Group Plc
13F
Company
1.1%
306,558
$6,611,000 31 Dec 2019
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
1%
292,600
$6,316,000 31 Dec 2019
13F
BLAIR WILLIAM & CO/IL
13F
Company
0.98%
286,691
$6,188,000 31 Dec 2019
13F
Tekla Capital Management LLC
13F
Company
0.97%
283,679
$6,123,000 31 Dec 2019
13F
DUALITY ADVISERS, LP
13F
Company
0.94%
274,272
$5,920,000 31 Dec 2019
13F

Institutional Holders of NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) as of Q1 2020

As of 31 Mar 2020, NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) was held by 234 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 177,174,980 shares. The largest 10 holders included Invesco Ltd., PRIMECAP MANAGEMENT CO/CA/, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, MAVERICK CAPITAL LTD, STATE STREET CORP, Bellevue Group AG, and Camber Capital Management LP. This page lists 235 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders
270
Q1 2020 holders
234
Holder diff
-36
Investor Q4 2019 Shares Q1 2020 Shares Share Diff Share Chg % Q4 2019 Value $ Q1 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .